Antidiarrheal drugs are used to treat abrupt diarrhea and possess the mechanism of slowing down the movement of the gut and helps to diminish the number of bowel movements and also make the stools less watery. Distinct causes of diarrhea can be a virus such as a rotavirus, hepatitis, a bacterium such as E.coli, Shigella, and parasites causing amoebiasis and giardiasis. Majority of the events of diarrhea are recognized to be concluded with simple dietary modifications and may not require treatment, however, in certain cases of severe diarrhea, laboratory assessment is requisite which includes blood tests, and stool specimen evaluation to analyze the type of diarrhea.

Scope of the Report:

The worldwide market for Antidiarrheal Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Antidiarrheal Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Johnson & Johnson

Novartis

GlaxoSmithKline

Proctor & Gamble

Pfizer

Actelion

Perrigo

Lupin

Glenmark Pharmaceuticals

Sanofi Aventis

Merck & Co.

Bayer

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

OTC Drugs

Prescription Drugs

Market Segment by Applications, can be divided into

Adults

Children

There are 15 Chapters to deeply display the global Antidiarrheal Drugs market.

Chapter 1, to describe Antidiarrheal Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Antidiarrheal Drugs, with sales, revenue, and price of Antidiarrheal Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Antidiarrheal Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Antidiarrheal Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Antidiarrheal Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 Antidiarrheal Drugs Introduction

1.2 Market Analysis by Type

1.2.1 OTC Drugs

1.2.2 Prescription Drugs

1.3 Market Analysis by Applications

1.3.1 Adults

1.3.2 Children

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Johnson & Johnson

2.1.1 Business Overview

2.1.2 Antidiarrheal Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Johnson & Johnson Antidiarrheal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Novartis

2.2.1 Business Overview

2.2.2 Antidiarrheal Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Novartis Antidiarrheal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 GlaxoSmithKline

2.3.1 Business Overview

2.3.2 Antidiarrheal Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 GlaxoSmithKline Antidiarrheal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Proctor & Gamble

2.4.1 Business Overview

2.4.2 Antidiarrheal Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Proctor & Gamble Antidiarrheal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Pfizer

2.5.1 Business Overview

2.5.2 Antidiarrheal Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Pfizer Antidiarrheal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Actelion

2.6.1 Business Overview

2.6.2 Antidiarrheal Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Actelion Antidiarrheal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Perrigo

2.7.1 Business Overview

2.7.2 Antidiarrheal Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Perrigo Antidiarrheal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Lupin

2.8.1 Business Overview

2.8.2 Antidiarrheal Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Lupin Antidiarrheal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Glenmark Pharmaceuticals

2.9.1 Business Overview

2.9.2 Antidiarrheal Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Glenmark Pharmaceuticals Antidiarrheal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Sanofi Aventis

2.10.1 Business Overview

2.10.2 Antidiarrheal Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Sanofi Aventis Antidiarrheal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Merck & Co.

2.11.1 Business Overview

2.11.2 Antidiarrheal Drugs Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Merck & Co. Antidiarrheal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Bayer

2.12.1 Business Overview

2.12.2 Antidiarrheal Drugs Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Bayer Antidiarrheal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Antidiarrheal Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Antidiarrheal Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Antidiarrheal Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Antidiarrheal Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Antidiarrheal Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Antidiarrheal Drugs Market Analysis by Regions

4.1 Global Antidiarrheal Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Antidiarrheal Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Antidiarrheal Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

4.5 South America Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

5 North America Antidiarrheal Drugs by Countries

5.1 North America Antidiarrheal Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Antidiarrheal Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Antidiarrheal Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

6 Europe Antidiarrheal Drugs by Countries

6.1 Europe Antidiarrheal Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Antidiarrheal Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Antidiarrheal Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

6.3 UK Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

6.4 France Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Antidiarrheal Drugs by Countries

7.1 Asia-Pacific Antidiarrheal Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Antidiarrheal Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Antidiarrheal Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

7.5 India Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

8 South America Antidiarrheal Drugs by Countries

8.1 South America Antidiarrheal Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Antidiarrheal Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Antidiarrheal Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Antidiarrheal Drugs by Countries

9.1 Middle East and Africa Antidiarrheal Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Antidiarrheal Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Antidiarrheal Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Antidiarrheal Drugs Sales and Growth Rate (2013-2018)

10 Global Antidiarrheal Drugs Market Segment by Type

10.1 Global Antidiarrheal Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Antidiarrheal Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Antidiarrheal Drugs Revenue and Market Share by Type (2013-2018)

10.2 OTC Drugs Sales Growth and Price

10.2.1 Global OTC Drugs Sales Growth (2013-2018)

10.2.2 Global OTC Drugs Price (2013-2018)

10.3 Prescription Drugs Sales Growth and Price

10.3.1 Global Prescription Drugs Sales Growth (2013-2018)

10.3.2 Global Prescription Drugs Price (2013-2018)

11 Global Antidiarrheal Drugs Market Segment by Application

11.1 Global Antidiarrheal Drugs Sales Market Share by Application (2013-2018)

11.2 Adults Sales Growth (2013-2018)

11.3 Children Sales Growth (2013-2018)

12 Antidiarrheal Drugs Market Forecast (2018-2023)

12.1 Global Antidiarrheal Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Antidiarrheal Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Antidiarrheal Drugs Market Forecast (2018-2023)

12.2.2 Europe Antidiarrheal Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Antidiarrheal Drugs Market Forecast (2018-2023)

12.2.4 South America Antidiarrheal Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Antidiarrheal Drugs Market Forecast (2018-2023)

12.3 Antidiarrheal Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Antidiarrheal Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Antidiarrheal Drugs Market Share Forecast by Type (2018-2023)

12.4 Antidiarrheal Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Antidiarrheal Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Antidiarrheal Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Antidiarrheal Drugs Picture

Table Product Specifications of Antidiarrheal Drugs

Figure Global Sales Market Share of Antidiarrheal Drugs by Types in 2017